PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma

Background. The outcome of patients with adenocarcinoma of the esophagogastric junction (AEG) remains poor. The programmed cell-death-protein-1 (PD-1), a co-inhibitory receptor primarily expressed by T-cells, represents a potential new therapeutic target. PD-1, PD-1 ligand 1 (PD-L1), and PD-L2 expre...

Full description

Bibliographic Details
Main Authors: Dagmar Kollmann, Desislava Ignatova, Julia Jedamzik, Yun-Tsan Chang, Gerd Jomrich, Andreas Baierl, Dmitry Kazakov, Michal Michal, Lars E. French, Wolfram Hoetzenecker, Tobias Schatton, Reza Asari, Matthias Preusser, Michael Gnant, Emmanuella Guenova, Sebastian F. Schoppmann
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:OncoImmunology
Subjects:
pd-1
pd-l1
pd-l2
esophageal adenocarcinoma
esophageal carcinoma
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1435226

Internet

http://dx.doi.org/10.1080/2162402X.2018.1435226

Similar Items